BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 466656)

  • 1. Levodopa and dopamine analogs: melanin precursors as antitumor agents in experimental human and murine leukemia.
    Wick MM
    Cancer Treat Rep; 1979 Jun; 63(6):991-7. PubMed ID: 466656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levodopa and dopamine analogs: dihydroxy and trihydroxybenzylamines as novel quinol antitumor agents in experimental leukemia in vivo.
    Wick MM
    Cancer Treat Rep; 1981; 65(9-10):861-7. PubMed ID: 7273019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levodopa and dopamine analogs as DNA polymerase inhibitors and antitumor agents in human melanoma.
    Wick MM
    Cancer Res; 1980 May; 40(5):1414-8. PubMed ID: 6768447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biologic evaluation of the dopamine analog N-acetyldopamine in experimental leukemia in mice.
    Wick MM; Mui A
    J Natl Cancer Inst; 1981 Feb; 66(2):351-4. PubMed ID: 6935484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor activity of amidoximes (hydroxyurea analogs) in murine tumor systems.
    Flora KP; van't Riet B; Wampler GL
    Cancer Res; 1978 May; 38(5):1291-5. PubMed ID: 639062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor activity and mechanism of action of the novel marine natural products mycalamide-A and -B and onnamide.
    Burres NS; Clement JJ
    Cancer Res; 1989 Jun; 49(11):2935-40. PubMed ID: 2720652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic and diabetogenic potential of two newly synthesized nitrosoureido sugars.
    Bernacki RJ; Wilson GL; Mossman BT; Angelino N; Kanter PM; Korytnyk W
    Cancer Res; 1985 Feb; 45(2):695-702. PubMed ID: 3881170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (R,R)-2,2'-[1,2-ethanediylbis[imino(1-methyl-2,1-ethanediyl)]]- bis[5-nitro-1H-benz[de]isoquinoline-1,3-(2H)-dione] dimethanesulfonate (DMP 840), a novel bis-naphthalimide with potent nonselective tumoricidal activity in vitro.
    Kirshenbaum MR; Chen SF; Behrens CH; Papp LM; Stafford MM; Sun JH; Behrens DL; Fredericks JR; Polkus ST; Sipple P
    Cancer Res; 1994 Apr; 54(8):2199-206. PubMed ID: 8174127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New substances with cytotoxic and antitumor effects. IV. In vitro effect of some veratrum alkaloids and their derivatives on leukemia P388 cells.
    Fuska J; Fusková A; Vassová A; Votický Z
    Neoplasma; 1981; 28(6):709-14. PubMed ID: 7339499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antineoplastic activity of azacarbazoles. I. Synthesis and antitumor properties of alpha-carboline and its selected derivatives.
    Wieczorek J; Peczyńska-Czoch W; Mordarski M; Kaczmarek L; Nantka-Namirski P
    Arch Immunol Ther Exp (Warsz); 1986; 34(3):315-21. PubMed ID: 3592935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor activity and bone marrow toxicity of aminoglucose mustard anticancer agents in mice.
    Cantrell JE; Green D; Schein PS
    Cancer Res; 1986 May; 46(5):2340-3. PubMed ID: 2938728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antitumor effect of 1,3,3,5,5-pentaziridino-1-thia-2,4,6-triaza-3,5- diphoshorine-1-oxide].
    Kato T; Takamoto S; Ota K
    Gan To Kagaku Ryoho; 1986 Dec; 13(12):3401-7. PubMed ID: 3789752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective toxicity of 5-S-cysteinyldopa, a melanin precursor, to tumor cells in vitro and in vivo.
    Fujita K; Ito S; Inoue S; Yamamoto Y; Takeuchi J; Shamoto M; Nagatsu T
    Cancer Res; 1980 Jul; 40(7):2543-6. PubMed ID: 6771000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental pharmacology of auromomycin in L1210 tumor cells in vitro and in vivo.
    Samy TS; Siegel PJ; Hopper WE; Krishan A
    Cancer Res; 1984 Aug; 44(8):3202-7. PubMed ID: 6589039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1-beta-D-arabinofuranosylcytosine metabolism and incorporation into DNA as determinants of in vivo murine tumor cell response.
    Riva CM; Rustum YM
    Cancer Res; 1985 Dec; 45(12 Pt 1):6244-9. PubMed ID: 2998596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro assessment of cytotoxic agents in murine cancers: comparison between antiproliferative and antimetabolic assays.
    Roobol C; Sips HC; Theunissen J; Atassi G; Bernheim JL
    J Natl Cancer Inst; 1984 Mar; 72(3):661-6. PubMed ID: 6583448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3,4-Dihydroxybenzylamine: a dopamine analog with enhanced antitumor activity against B16 melanoma.
    Wick MM
    J Natl Cancer Inst; 1979 Dec; 63(6):1465-7. PubMed ID: 292814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor activity of a novel antitumor antibiotic, quinocarmycin citrate (KW2152).
    Fujimoto K; Oka T; Morimoto M
    Cancer Res; 1987 Mar; 47(6):1516-22. PubMed ID: 2434218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Facilitation of the effects of L-DOPA by alpha-methyldopa].
    Uspenskiĭ AE; Korobov NV
    Biull Eksp Biol Med; 1976 Mar; 81(3):314-6. PubMed ID: 986203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice.
    Citarella RV; Wallace RE; Murdock KC; Angier RB; Durr FE; Forbes M
    Cancer Res; 1982 Feb; 42(2):440-4. PubMed ID: 7055799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.